Breaking News
Sort by:
Top Post
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
KKR to Acquire Bushu Pharmaceuticals
KKR, a leading global investment firm, and Bushu Pharmaceuticals have announced the signing of definitive […]
SynAct Pharma to Make Strategic Acquisition of Swiss Biotech Company TXP Pharma
SynAct Pharma AB has announced that the company has entered into a conditional agreement on […]
Molecular Devices Acquires Cellesce, Expanding Industrywide Accessibility to Organoids
Molecular Devices, a leading provider of high-performance life science solutions, has announced the acquisition of […]
Abiogen Pharma Acquires German Pharmaceutical Company, Altamedics
Abiogen Pharma has completed the acquisition of the German pharmaceutical distribution company Altamedics GmbH which […]
Essential Pharma Announces the Acquisition of HALDOL
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access […]
Medical Mutual Finalizes Acquisition of Reserve National Insurance Company
On Dec. 1, 2022, Medical Mutual closed on the acquisition of Reserve National Insurance Company, […]
Inszone Insurance Services Completes Acquisition of Kirsch Insurance Group
Inszone Insurance Services, a rapidly growing, national provider of benefits, personal and commercial lines insurance, […]
Focus-X Therapeutics Successfully Reached an Acquisition Agreement with Full-Life Technologies
Focus-X Therapeutics, a nuclide drug company that was invested in and incubated by Viva Biotech, […]
Rocket Pharmaceuticals Completes Acquisition of Renovacor
Rocket Pharmaceuticals, a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic […]
AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy
AstraZeneca has announced an agreement to acquire Neogene Therapeutics, a global clinical-stage biotechnology company pioneering […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more